Publications

Publications by Daniel D. Truong, M.D. 

  1. Truong DD, Yebenes JG, Pezzoli G, Jackson LV, Fahn S: Glycine involvement in DDT induced myoclonus. Movement Disorders 3(3):77-87, 1988. 
  2. Truong DD, Fahn S: Therapeutic trial with glycine in myoclonus. Movement Disorders 3(3):222-232, 1988. 
  3. Truong DD, Bressman S, Shale H, Fahn S: Clonazepam, haloperidol and clonidine in tic disorders. Southern Medical Journal 81:(9)1103-05, 1988.
  4. Pezzoli G, Fahn S, Truong DD, et al: Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats. Brain Research 459:398-403, 1988. 
  5. Cordova MA, Truong DD, Blackburn JG: Preliminary neurologic and neurophysiologic findings in ectodermal dysplasias. Birth Defects 24(2):65-71, 1988.
  6. Truong DD, Sczesnii B, Fahn S, Gross J. et al: Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases. Language: German. Nervenarzt 59(2):103-09, 1988. 
  7. Truong DD, Galloway M, Pezzoli G, Jamrozik A, Fahn S: Milacemide increased 5-hydroxytryptamine and dopamine levels in rat brain - Possible mechanisms of milacemide antimyoclonic property in the p,p'-DDT-induced myoclonus. Pharmacology Biochemistry & Behavior 32:993-1001, 1989.
  8. Truong DD, Diamond B, Pezzoli G, Mena M, Fahn S: Monomine oxidase  inhibitory properties of milacemide in rats. Life Science 44:1059- 66, 1989.
  9. Truong DD, Harding A, Morgan-Hughes JA, Marsden CD: Movement disorders in mitochondrial myopathies: A study of nine cases with two autopsy studies. Movement Disorders 5(2):109-117, 1990.
  10. Truong DD, Rontal M, Rolnick M, Aronson AE, Mistura K: Double blind controlled study of botulinum toxin in adductor spasmodic dysphonia. The Laryngoscope Journal 101(6):630-634, 1991.
  11. Truong DD, Dubinski R, Hermanowicz N, Olson W, Silverman B, Koller W: Post traumatic torticollis.  Archives of Neurology 48: 221-23, 1991.
  12. Rontal M, Rontal E, Rolnick M; Merson R, Silverman B, Truong DD:  A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: A preliminary report. The Laryngoscope Journal 101(8):911-914, 1991.
  13. Fazzini E, Dwork AJ, Blum C, Burke R, Cote L, Goodman RR, Jacobs TP, Naini AB, Pezzoli G, Pullman, Solomon RA, Truong DD, Weber CJ, Fahn S: Stereotaxic implantation of autologous adrenal medulla into caudate nucleus in four patients with parkinsonism: One year follow-up.  Archives of Neurology 48(8): 813-820, 1991.
  14. Sczesni, Becker H, Schroder J, Bittkau S, von Baumgarten F, Truong DD, Przuntek H: Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases. Language: German. Wiener Klinische Wochenschrift 103(1):21-6, 1991.
  15. Hermanowicz N, Truong DD: Treatment of oromandibular dystonia with botulinum toxin. Laryngoscope 101:1216-1218. November 1991. 
  16. Kartsounis LD, Truong DD, Morgan-Hughes JA, Harding AE:  The Neuropsychological Features of Mitochondrial Myopathies and Encephalomyopathies.  Archives of Neurology 49(2):158-160, 1992
  17. Truong DD, Matsumoto R, Schwartz PH, Hussong MJ, Wasterlain CG.  Novel rat cardiac arrest model of posthypoxic myoclonus.  Movement Disorders 9, 201-206, 1994.
  18. Jaw SP, Hussong MJ, Matsumoto RR, Truong DD.  Involvement of 5-HT2 receptors in the post-hypoxic stimulus sensitive myoclonus in rats. Pharmacology, Bioch and Behavior 49, 129-31, 1994.
  19. Jamrozik Z, De Yebenes JG, Truong DD, Cadet J.  Intrastriatal infusion of amiloride increases rotations in 6-OHDA lesioned rats and “down-regulates” D2 receptors in the striatum and 5-HT2A receptors in the cortex.  Pol J of Pharmacology 46, 417-22, 1994.
  20. Jaw SP, Su DD, Matsumoto RR, Truong DD.  Alterations of brain levels of phosphoinositidase-C-linked G11a/qa proteins in post-cardiac-arrest rats. Stroke 26, 1067-71, 1995.
  21. Matsumoto RR, Aziz N and Truong DD.  Indol level in animal model of post-hypoxic myoclonus.  Pharmacology, Bioch and Behavior, 50, 533-538, 1995.
  22. Truong D.D., Sandroni P, Van Den Noort S, Matsumoto RR.  Diphenhydramine is effective in the treatment of idiopathic dystonia.  Archives of Neurology, 1995 Apr, 52(4):405-7.
  23. Matsumoto RR, Nguyen DC and Truong DD.  Strychnine insensitive glycine site antagonists attenuate a cardiac arrest induced movement disorders. Eur J Pharmacol 275:117-123, 1995. 
  24. Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD and de Costa BR.  Characterization of two novel sigma ligands: antidystonic effects in rats suggest sigma receptor antagonism.  Eur J Pharmacol. 280, 301-310, 1995.
  25. Jaw SP, T. Dang and Truong DD. Chronic treatments with 5-HT1A agonists attenuate posthypoxic myoclonus in rats. Pharmacol. Biochem. Behav. 52, 577-580, 1995.
  26. Jaw SP, Su DD, Vuong QVT and Truong DD.  Regulation of tyrosine protein kinase receptor Trk-B and motor function in rats following cardiac arrest. Pharmacol. Biochem. Behav. 52, 443-446, 1995.
  27. Matsumoto RR, Hussong MJ and Truong DD. Effects of selective 5-HT ligands on post-hypoxic audiogenic myoclonus.  Movement Disorders 10, 615-21, 1995.
  28. Jaw SP, Su DD and Truong DD. Astrocyte-derived growth factor (S100B) and motor function on rats following cardiac arrest. Pharmacol. Biochem. Behav. 52, 667-670, 1995.
  29. van’t Groenewout JL, Stone MR, Vo VN, Truong DD, Matsumoto RR.  Evidence for the Involvement of histamine in the antidystonic effects of diphenhydramine.  Exp. Neurol. 134, 253-260, 1995.
  30. Kanthasamy A, Matsumoto RR, Gunasekar PG,  and Truong DD.  Excitoprotective effect of felbamate in cultured cortical neurons.  Brain Research. 705, 97-104, 1995.
  31. Jaw, S.P., Su DD and Truong DD.  Expression of Bcl-2 and Bax in the frontal/parietal cortex of the rat following cardiac arrest. Brain Res Bul.  38(6) 577-580, 1995.
  32. Kanthasamy A, Vu TQ, Yun RJ and Truong DD.  Antimyoclonic effects of gabapentin in animal model of myoclonus.  Eur J Pharmacology. 546: 741-745, 1995.
  33.  Jaw, S.P., Nguyen B, Vuong QTV, Trinh TA, Nguyen M and Truong DD.  Effects of GABA uptake inhibitors on posthypoxic myoclonus in rats.  Brain Res Bul.  39, 189-92, 1996.
  34. Matsumoto RR; Bowen WD; Walker JM; Patrick SL; Zambon AC; Vo VN; Truong DD; De Costa BR; Rice KC.  Dissociation of the motor effects of (+)-pentazocine from binding to sigma 1 sites. European Journal of Pharmacology, 301(1-3):31-40, 1996.
  35. Jaw SP and Truong DD.   Induction of glia-derived neurotrophic factor in the rat brain following cardiac arrest. Brain Res Bull. In press.
  36. J.T. Cheng, Liu AW, Wasmuth J, Liu BP and Truong DD.  Anticipation in adult onset dystonia. Neurology, 1996 Jul, 47(1):215-9.
  37. Kanthasamy A, Kanthasamy A, Matsumoto R, Vu T and Truong DD. Neuroprotective effects of strychnine-insensitive glycine site NMDA antagonist (R)-HA-966 in experimental model of Parkinson’s disease.  Brain Research, 759; 1-8, 1997. 
  38. Truong DD, Cullis P, O'Brien CF, Koller M, Villegas TF, Garces A, Wallace JD.  Botbtm (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A resistant cervical dystonia patients.  Movement Disorders: 12, 772-75, 1997.
  39. Truong DD: Botulinum toxin therapy. Western Journal of Medicine 155(1):69-70, July 1991. 
  40. Hermanowicz N and Truong DD: Development of Botulinum toxin therapy. Western Journal of Medicine 163 (5): 472-73, 1995. 
  41. Kanthasamy A, Matsumoto R and Truong DD.  Animal model of myoclonus. Special issue of Clinical Neuroscience 3(4):236-45, 1995-96.
  42. Glanzman RL, Gelb DJ, Drury I, Bromberg MB, Truong DD: Brachial plexopathy after botulinum toxin injections. Neurology 40:1143, 1990.
  43. Truong DD, Hermanowicz N: Clinical evaluation of bi-directional torticollis. Movement Disorders 5(2):181, 1990.
  44. Truong DD, Hermanowicz N, Mistura K: Rabbit syndrome treated with botulinum. Southern Medical Journal 83(7):854, 1990. 
  45. Truong DD, Hermanowicz N, Rontal M: Botulinum toxin in treatment of tardive dyskinetic syndrome. Journal of Clinical Psychopharmacology  10(6):438-39, 1990.
  46. Truong D.D., Matsumoto RR.  Diphenhydramine is effective in the treatment of idiopathic dystonia.  Reply. Archives of Neurology.  53:405, 1996.
  47. Truong DD, Hsu CH, Scott T, Holgate R: Occlusion of the transverse sinus by meningioma simulating pseudotumor cerebri. Neuroopthalmology 7:112-17, 1987.
  48. Truong DD, Szesni B, Fahn S, et al: Neuroleptic malignant syndrome-four different cases. Nervenarzt 59:103-109, 1988.

    49. BOOK CHAPTERS: 
  49. Truong DD, Fahn S: An early description of dystonia from Marcus Walter Schwalbe and information on his life.  Chapter in Dystonia. Edited by Stanley Fahn, C David Marsden, & Donald Calne. Raven Press, N.Y., 651-664, 1988. 
  50. Truong DD, LeWitt P: Budipine in Parkinson's Disease. Chapter in Therapy of Parkinson's Disease, Edited by William Koller. Marcel Dekker, N.Y., 399-404, 1990. 
  51. Truong DD, Hermanowicz N.  Cranial nerve 9 (glossopharyngeal) and 10 (vagus). Chapter in Textbook of Clinical Neurology to be published by W.B. Saunders.  Eds: Goetz C.G. and Pappert E.J. 
  52. Cullis P, O'Brien CF, Truong DD, Koller M, Villegas TF, Wallace JD.  Botbtm (botulinum toxin type B): an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.  Dystonia III, Edited by Stanley Fahn, C David Marsden, & Mahlein Delong. Raven Press, N.Y.. 

Publications by Karen Frei, M.D. 

  1. Karen Frei, MD; Nicholas Petronas, MD; Kevin Crutchfield, MD; Roscoe Brady, MD; Raphael Schiffman, MD; MRI in Mucolipidosis Type IV, [Abstract] Journal of Neuroimaging 1997; 7:63.
  2. Karen Frei, MD; Nicholas Petronas, MD; Kevin Crutchfield, MD; Roscoe Brady, MD; Raphael Schiffman, MD; Mucolipidosis Type IV: Characteristic MRI Findings Neurology August 1998.
  3. Kevin Crutchfield, MD; Nicholas Petronas, MD; Tapas Banerjee, Norman Barton, MD; James D’Ambrosia, Karen Frei, MD; Anne Tournay, MD; J.C. Scott Leland, MD; Roscoe Brady, MD; Raphael Schiffman, MD; Quantitiation of Fabry Disease Progression Utilizing Cerebral MRI, [Abstract] Neurology March 1997 Vol 48 (3)  supplement 2 pg A362.
  4. Kevin Crutchfield, MD; Nicholas Petronas, MD; Tapas Banerjee, Norman Barton,MD; James D’Ambrosia, Karen Frei, MD; Anne Tournay, MD; J.C. Scott Leland, MD; Roscoe Brady, MD; Raphael Schiffmann, MD; Quantitation of Fabry Disease Progression Utilizing Cerebral MRI, Neurology  June 1998 (in press).
  5. Heidi Oletsky, MD; Karen Frei, MD; Jacqueline Greenfield; Raphael Schiffman, MD and  Susumu Sato, MD; Electroencephalographic Findings in Patients with Mucolipidosis Type 4 (in press).
  6. Raphael Schiffman, Nancy P. Dwyer, Irina  A. Lubensky, Maria Tsokos, Vincent E. Sutliff, John S. Latimer, Karen P. Frei, Roscoe O. Brady, Norman W. Barton, E. Joan Blanchette-Mackie, and  Ehud Goldin; Constitutive Achlorhydria in  Mucolipidiosis Type IV (in press).

Copyright © 2006. www.pmdi.org

Last update: January 14, 2006